.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Merck
AstraZeneca
Cantor Fitzgerald
Accenture
Teva
Johnson and Johnson
Harvard Business School
Healthtrust
Colorcon

Generated: December 14, 2017

DrugPatentWatch Database Preview

Loxapine succinate - Generic Drug Details

« Back to Dashboard

What are the generic sources for loxapine succinate and what is the scope of loxapine succinate freedom to operate?

Loxapine succinate
is the generic ingredient in two branded drugs marketed by Elite Labs Inc, Lannett Holdings Inc, Mylan, Watson Labs, and Actavis Labs Ut Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for loxapine succinate. Ten suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MylanLOXAPINE SUCCINATEloxapine succinateCAPSULE;ORAL076762-004Nov 1, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsLOXAPINE SUCCINATEloxapine succinateCAPSULE;ORAL072204-001Jun 15, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Elite Labs IncLOXAPINE SUCCINATEloxapine succinateCAPSULE;ORAL076868-003Aug 4, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Elite Labs IncLOXAPINE SUCCINATEloxapine succinateCAPSULE;ORAL076868-004Aug 4, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Lannett Holdings IncLOXAPINE SUCCINATEloxapine succinateCAPSULE;ORAL090695-004Sep 26, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateTABLET;ORAL017525-007Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: loxapine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut IncLOXITANEloxapine succinateCAPSULE;ORAL017525-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
US Army
Fish and Richardson
AstraZeneca
Healthtrust
Queensland Health
Novartis
US Department of Justice
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot